Ken Cacciatore analyst

Currently out of the existing stock ratings of Ken Cacciatore, 100 are a BUY (71.94%), 38 are a HOLD (27.34%), 1 are a SELL (0.72%).

Ken Cacciatore

Work Performance Price Targets & Ratings Chart

Analyst Ken Cacciatore, carries an average stock price target met ratio of 36.94% that have a potential upside of 29.45% achieved within 129 days. Previously, Ken Cacciatore worked at COWEN.

Ken Cacciatore’s has documented 276 price targets and ratings displayed on 28 stocks. The coverage was on the Healthcare sector.

Most recent stock forecast was given on JAZZ, Jazz Pharmaceuticals PLC at 01-May-2024.

Wall Street Analyst Ken Cacciatore

Analyst best performing recommendations are on ENDP (ENDO INTERNATIONAL PLC).
The best stock recommendation documented was for BHVN (BIOHAVEN PHARMACEUTICAL HOLDING CO LTD) at 3/1/2024. The price target of $55 was fulfilled within 3 days with a profit of $5.46 (11.02%) receiving and performance score of 36.74.

Average potential price target upside

ADMS Adamas Pharmaceuticals AGN Allergan plc BCRX BioCryst Pharmaceuticals BHVN Biohaven Pharmaceutical Holding Co Ltd ENDP Endo International PLC HZNP Horizon Pharma PLC JAZZ Jazz Pharmaceuticals PLC TEVA Teva Pharma Industries Ltd ADR AMRN Amarin PLC ARQT Arcutis Biotherapeutics  CHRS Coherus BioSciences MYL Viatris VTRS Viatris AMAG AMAG Pharmaceuticals AUPH Aurinia Pharmaceuticals RVNC Revance The EYPT Eyepoint Pharmaceuticals ISEE IVERIC bio TXMD TherapeuticsMD AERI Aerie Pharmaceuticals BLCO Bausch + Lomb Corp BHC Bausch Health Companies OCUL Ocular Therapeutix TAK Takeda Pharmaceutical Co Ltd ADR ARAV Aravive IMPL Impel Neuropharma KMPH KemPharm MNTA Momenta Pharmaceuticals

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date

Price targets met ratio

Average potential upside

Average Time (Days) For PT To Be Met

Performance score

Hold

$12.5

3 years 10 months 20 days ago
(16-Nov-2021)

0/3 (0%)

$7.13 (132.77%)

Hold

$8

$-0.22 (-2.68%)

$7

3 years 11 months 24 days ago
(12-Oct-2021)

4/8 (50%)

$-0.07 (-0.87%)

95

Hold

$14

3 years 11 months 24 days ago
(12-Oct-2021)

3/7 (42.86%)

$9.25 (194.74%)

87

Hold

$12

3 years 11 months 24 days ago
(12-Oct-2021)

0/6 (0%)

$7 (140.00%)

Buy

$6

$-2.22 (-27.01%)

$20

3 years 11 months 24 days ago
(12-Oct-2021)

0/2 (0%)

$3.2 (23.94%)

Show more analysts

To gain access for the analyst/ stock price target chart please use a computer

What Year was the first public recommendation made by Ken Cacciatore?

On 2013

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?